Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters
Open Access
- 1 June 2018
- journal article
- Published by Springer Science and Business Media LLC in The Egyptian Journal of Internal Medicine
- Vol. 30 (2), 78-82
- https://doi.org/10.4103/ejim.ejim_86_17
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Role of spleen-derived IL-10 in prevention of systemic low-grade inflammation by obesity [Review]Endocrine Journal, 2017
- Interleukin 10 and clustering of metabolic syndrome components in pediatricsEuropean Journal of Clinical Investigation, 2014
- Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsWorld Journal of Hepatology, 2014
- A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and LiverDiabetes, 2012
- Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese femalesJournal of Translational Medicine, 2011
- Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in MacrophagesOnline Journal of Public Health Informatics, 2009
- Could inflammatory markers help diagnose nonalcoholic steatohepatitis?European Journal of Gastroenterology & Hepatology, 2009
- Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?Journal of Inflammation, 2009
- Obesity induces a phenotypic switch in adipose tissue macrophage polarizationJCI Insight, 2007
- Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA BindingOnline Journal of Public Health Informatics, 1999